1. Home
  2. VERA vs AHCO Comparison

VERA vs AHCO Comparison

Compare VERA & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • AHCO
  • Stock Information
  • Founded
  • VERA 2016
  • AHCO 2012
  • Country
  • VERA United States
  • AHCO United States
  • Employees
  • VERA N/A
  • AHCO N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • AHCO Medical/Nursing Services
  • Sector
  • VERA Health Care
  • AHCO Health Care
  • Exchange
  • VERA Nasdaq
  • AHCO Nasdaq
  • Market Cap
  • VERA 1.5B
  • AHCO 1.3B
  • IPO Year
  • VERA 2021
  • AHCO N/A
  • Fundamental
  • Price
  • VERA $28.61
  • AHCO $9.68
  • Analyst Decision
  • VERA Buy
  • AHCO Strong Buy
  • Analyst Count
  • VERA 9
  • AHCO 5
  • Target Price
  • VERA $62.75
  • AHCO $13.60
  • AVG Volume (30 Days)
  • VERA 1.6M
  • AHCO 1.1M
  • Earning Date
  • VERA 11-05-2025
  • AHCO 11-04-2025
  • Dividend Yield
  • VERA N/A
  • AHCO N/A
  • EPS Growth
  • VERA N/A
  • AHCO N/A
  • EPS
  • VERA N/A
  • AHCO 0.55
  • Revenue
  • VERA N/A
  • AHCO $3,255,213,000.00
  • Revenue This Year
  • VERA N/A
  • AHCO $0.89
  • Revenue Next Year
  • VERA N/A
  • AHCO $6.84
  • P/E Ratio
  • VERA N/A
  • AHCO $16.64
  • Revenue Growth
  • VERA N/A
  • AHCO N/A
  • 52 Week Low
  • VERA $18.53
  • AHCO $7.11
  • 52 Week High
  • VERA $51.27
  • AHCO $11.63
  • Technical
  • Relative Strength Index (RSI)
  • VERA 50.88
  • AHCO 55.94
  • Support Level
  • VERA $27.55
  • AHCO $8.99
  • Resistance Level
  • VERA $29.90
  • AHCO $9.56
  • Average True Range (ATR)
  • VERA 2.02
  • AHCO 0.46
  • MACD
  • VERA 0.06
  • AHCO -0.03
  • Stochastic Oscillator
  • VERA 62.09
  • AHCO 41.07

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: